These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts from various specialties involved in the management of CCA, as well as patient/public representatives from AMMF (the Cholangiocarcinoma Charity) and PSC Support. Quality of evidence is presented using the Appraisal of Guidelines for Research and Evaluation (AGREE II) format. The recommendations arising are to be used as guidance rather than as a strict protocol-based reference, as the management of patients with CCA is often complex and always requires individual patient-centred considerations.
Read More
Guidance
Liver
BSG Endorsed Guidance: ELF test (Enhanced Liver Fibrosis)
clinical-resource/ELF-test-(Enhanced-Liver-Fibrosis)
The ELF test is a non-invasive blood test which combines three direct serum biomarkers of liver fibrosis. It is for people people with primary non-alcoholic fatty liver disease (NAFLD) or metabolic dy
Endoscopy
Quality Improvement
British Society of Gastroenterology Endoscopic Retrograde Cholangiopancreatography (ERCP) Quality Improvement Programme: minimum service standards and good practice statements
clinical-resource/ERCP-Quality-Improvement-Programme
In 2014, the British Society of Gastroenterology (BSG) published a standards framework outlining key performance indicators for ERCP practitioners and services.